Aimei Health Technology (NASDAQ:AFJK) Trading 4.2% Higher – Should You Buy?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK)’s share price rose 4.2% on Monday . The stock traded as high as $50.00 and last traded at $50.50. Approximately 4,247 shares changed hands during trading, a decline of 79% from the average daily volume of 19,772 shares. The stock had previously closed at $48.46.

Wall Street Analysts Forecast Growth

Several research firms recently commented on AFJK. Wall Street Zen upgraded Aimei Health Technology to a “sell” rating in a research note on Saturday, January 17th. Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Aimei Health Technology Price Performance

The stock has a market cap of $309.06 million, a price-to-earnings ratio of 240.49 and a beta of -3.65. The business’s fifty day simple moving average is $48.81 and its 200 day simple moving average is $24.58.

Aimei Health Technology (NASDAQ:AFJK) last issued its earnings results on Tuesday, November 18th. The company reported $0.06 earnings per share for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Dakota Wealth Management acquired a new stake in shares of Aimei Health Technology during the 4th quarter worth approximately $406,000. Geode Capital Management LLC bought a new position in Aimei Health Technology during the 4th quarter worth $413,000. Wellspring Financial Advisors LLC acquired a new stake in Aimei Health Technology in the second quarter worth $133,000. Clear Street LLC increased its position in Aimei Health Technology by 63.8% in the second quarter. Clear Street LLC now owns 39,525 shares of the company’s stock worth $441,000 after buying an additional 15,399 shares during the period. Finally, Clear Street Group Inc. bought a new stake in Aimei Health Technology in the third quarter valued at $691,000. 45.58% of the stock is currently owned by institutional investors and hedge funds.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.